Tag: Upsized
NuStar Energy L.P. Announces Pricing of Upsized Equity Offering of Common...
NuStar Energy L.P. NS (the "Partnership") announced today the pricing of an offering of 13,000,000 common units for gross proceeds of approximately $199.6...
Kimbell Royalty Partners, LP Announces Pricing of Upsized Public Offering of...
FORT WORTH, Texas, Aug. 2, 2023 /PRNewswire/ -- Kimbell Royalty Partners, LP KRP ("Kimbell") today announced the pricing of its public offering of 7,250,000...
Caribou Biosciences Announces Pricing of Upsized $125 Million Public Offering –...
BERKELEY, Calif., July 13, 2023 (GLOBE NEWSWIRE) -- Caribou Biosciences, Inc. CRBU, a leading clinical-stage CRISPR genome-editing biopharmaceutical company, today announced...
AST SpaceMobile, Inc. Announces Pricing of Upsized Offering of Class A...
AST SpaceMobile, Inc. ASTS (the "Company" or "AST SpaceMobile") announced today the pricing and upsizing of its previously announced public offering of its...
RadNet Announces Pricing of Upsized Public Offering of Common Stock –...
LOS ANGELES, June 13, 2023 (GLOBE NEWSWIRE) -- RadNet, Inc. RDNT, a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic...
NewAmsterdam Pharma Announces Pricing of Upsized Secondary Offering of Ordinary …...
NAARDEN, The Netherlands and MIAMI, June 06, 2023 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. NAMS "NewAmsterdam" or the "Company"))), a...
Cogent Biosciences Announces Pricing of Upsized Public Offering of Shares of...
WALTHAM, Mass. and BOULDER, Colo., June 06, 2023 (GLOBE NEWSWIRE) -- Cogent Biosciences, Inc. COGT, a biotechnology company focused on developing precision...
4D Molecular Therapeutics Announces Pricing of Upsized Public Offering of Common…...
EMERYVILLE, Calif., May 04, 2023 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics, Inc. FDMT, a clinical-stage biotherapeutics company harnessing the power of...
Matador Resources Company Prices Upsized Offering of $500 Million of Senior...
Matador Resources Company MTDR ("Matador") today announced that it has priced a private offering of $500 million of 6.875% senior unsecured notes due...
2seventy bio Announces Pricing of Upsized Public Offering of Common Stock...
2seventy bio, Inc. ("2seventy bio") TSVT, a cell and gene therapy company focused on the research, development, and commercialization of transformative treatments for...